<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-326
Date of Submission: 2024-12-30

This report was submitted by a Other Healthcare Professional from Sharp and Sons Medical Center concerning patient ANON-PX-1509. The subject is an adult female with a significant medical history including osteoarthritis, type 2 diabetes, anxiety. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Amoxicillin administered via the Intravenous route at a dosage of 19mg, initiated on 2024-10-15 for Bacterial infection and discontinued on 2024-12-07.

On approximately 2024-10-18, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Maculopapular Rash, Diarrhea. The Maculopapular Rash was classified as Moderate in severity. This necessitated clinical intervention. The documented action was: Prescribed both and advised should. The current patient status regarding this symptom is 'Recovering'. The Diarrhea was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed sport and advised party. The current patient status regarding this symptom is 'Fatal'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 4 was calculated, The assessment concluded the relationship was 'Possible'. Dechallenge/Rechallenge status was noted as: 'Positive dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

</data>
report_id: ADR-2024-326
report_date: '2024-12-30'
patient_details:
  patient_id: ANON-PX-1509
  gender: Female
  relevant_history:
  - osteoarthritis
  - type 2 diabetes
  - anxiety
suspected_drugs:
- drug_name: Amoxicillin
  dosage: 19mg
  route_of_administration: Intravenous
  start_date: '2024-10-15'
  indication_for_use: Bacterial infection
  end_date: '2024-12-07'
adverse_reactions:
- symptom_name: Maculopapular Rash
  onset_date: '2024-10-18'
  severity: Moderate
  outcome: Recovering
  intervention_required: true
  intervention_details: Prescribed both and advised should.
- symptom_name: Diarrhea
  onset_date: '2024-10-18'
  severity: Life-threatening
  outcome: Fatal
  intervention_required: true
  intervention_details: Prescribed sport and advised party.
causality_assessment:
  assessment_conclusion: Possible
  dechallenge_rechallenge: Positive dechallenge
  naranjo_score: 4
reporting_facility: Sharp and Sons Medical Center
reporter_type: Other Healthcare Professional
